Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
ProclaimRx has introduced an enterprise-grade AI platform designed to transform complex pharmaceutical data into real-time, decision-ready intelligence, as announced in a press release. The company also appointed Eugene Lee as Chief Commercial Officer and Kathy Contratto as Vice President of Customer Operations.
The European Society for Medical Oncology has released its first framework for the responsible use of large language models in cancer care, outlining safety and governance standards for patient, clinician, and institutional applications.
Health Data Analytics Institute announced the general availability of its real-time, EHR-embedded AI chart summaries at HLTH 2025 in Las Vegas, expanding its HealthVision platform for clinicians managing complex patient records.
iOncologi has received a U.S. patent for its RNA-based method to enhance tumor response to immune checkpoint inhibitors, building on findings published in Nature Biomedical Engineering and data presented at ESMO 2025.
Akeso announced that its Phase III HARMONi-6 trial showed ivonescimab plus chemotherapy significantly prolonged progression-free survival in advanced squamous non-small cell lung cancer compared to tislelizumab plus chemotherapy.
Plug and Play and Indiana University have launched the IU LAB Lifetech Accelerator in Indianapolis to support global startups in therapeutics, medical devices, diagnostics, and biotechnology. The program will host up to 40 startups annually, beginning its first cohort in October 2025.
Adlib has renewed its SOC 2 Type II attestation and HIPAA compliance validation, ensuring continued data protection for enterprises in regulated sectors such as healthcare, manufacturing, and energy.
DarioHealth Corp. has added six new employer clients across sectors such as manufacturing and education, representing tens of thousands of employees, and introduced a new value-based pricing model linking payments to engagement and clinical outcomes.
The Novo Nordisk Foundation has committed up to DKK 200 million to establish the Global Pathogen Analysis Platform, an AI-powered infrastructure aimed at strengthening global pandemic preparedness through open genomic data analysis tools.
EY has acquired Greece-based Veeva services partner Aqurance to strengthen its Veeva Centers of Excellence and expand clinical, regulatory, and commercial capabilities for global life sciences clients.
Cumulus Neuroscience presented new data at the ISCTM Autumn Conference and ECNP Congress, highlighting the use of its NeuLogiq Platform for digital biomarkers in CNS clinical trials. The company showcased studies on major depressive disorder and dementia, showing improved sensitivity and efficiency in trial design.
AcuityMD has announced an expansion of its AI platform, introducing new tools to improve sales performance and strategic decision-making for medical device companies.
Notable has introduced Flow AI, a conversational assistant designed to streamline workflow automation in healthcare, as announced in a press release.
Hahn Labs has launched a new AI-powered solution to streamline healthcare call handling during open enrollment, significantly reducing wait times and costs.
Hoth Therapeutics has expanded its AI initiative by adopting the NVIDIA AI Enterprise platform to enhance drug development and predictive analytics.
Nucs AI has announced the expansion of its leadership team with new appointments to advance AI-driven prostate cancer diagnostics and treatment planning.
DPR Construction's latest report reveals how AI is transforming healthcare construction by improving project delivery and efficiency.
BD and Opentrons have announced a multi-year collaboration to integrate robotic automation into BD's single-cell multiomics instruments, enhancing disease research and drug development.
POMDOCTOR Limited, a leading online medical services platform in China, has announced the pricing of its initial public offering on Nasdaq, aiming to raise approximately $20 million.
TransCelerate BioPharma is pushing forward with its Digital Data Flow initiative to modernize clinical trials through digital protocols, as announced in a recent press release.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
